You are here: Industry Insights > CEO

News List

After a strong few years, Aimmune CEO Dilly to step down in 2018 fiercebiotech
November 07, 2017
After a good run that has seen his company pass key tests, set up deals with Big Pharmas and have its market cap top $1.5 billion, Aimmune chief Stephen Dilly, M.B.B.S., Ph.D., is calling it a day.
AbbVie promises it's sticking with CEO's price-hike pledge, at least through 2018 fiercepharma
September 28, 2017
Facing heavy backlash over reports its executives considered dropping the company's pricing pledge, AbbVie maintained on Tuesday that it's sticking with the 10% price-hike limit for 2018.
Novartis appoints Vasant Narasimhan as CEO expressbpd
September 05, 2017
The Board of Directors of Novartis has appointed Vasant (Vas) Narasimhan, MD, Global Head of Drug Development and CMO, as CEO
BioAscent appoints new CEO financialexpress
July 14, 2017
Paul Smith, the new CEO, will help in the expansion of BioAscent’s discovery services offering
Adherium appoints new CEO to drive global growth biospectrumasia
June 13, 2017
He has also served as Director of Product Development at Delphi Medical Systems
Mundipharma’s CEO ranked among Pharma business captains pharmaasia
May 31, 2017
Mundipharma’s Raman Singh ranked among world’s leading pharma business captains.
Defibtech selects Robert Reinhardt as new CEO pharmaasia
April 19, 2017
Reinhardt will succeed Gintaras Vaisnys, the company's co-founder and current CEO, Vaisnys will remain as an advisor to Defibtech’s board and management.
Repros Names Dillaha its Permanent President and CEO americanpharmaceuticalreview
April 12, 2017
Repros Therapeutics Inc.® has announced that the Company’s Board of Directors has appointed Larry Dillaha, M.D., the President and Chief Executive Officer of the Company, effective immediately.
Teva CEO Erez Vigodman steps down from role firstwordpharma
February 08, 2017
Teva announced that CEO Erez Vigodman is stepping down from his position following an agreement with the board of directors. "I believe that now is the right time for me to step down," said Vigodman, adding "I am confident that the company's future is bri

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page